Cargando…
Efficacy and safety of left atrial appendage closure compared with oral anticoagulation in atrial fibrillation: a meta-analysis of randomized controlled trials and propensity-matched studies
BACKGROUNDS: Two recent randomized controlled trials (RCTs), the PROTECT-AF and the PREVAIL, showed that in atrial fibrillation (AF) patients, left atrial appendage closure (LAAC) is comparable to oral anticoagulants (OAC) in the prevention of stroke and could also possibly reduce mortality. Neverth...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10565038/ https://www.ncbi.nlm.nih.gov/pubmed/37829693 http://dx.doi.org/10.3389/fcvm.2023.1212161 |
_version_ | 1785118609295540224 |
---|---|
author | Franchin, Luca Piroli, Francesco Demola, Pierluigi Mantovani, Francesca Iannaccone, Mario Manfredi, Roberto D’Ascenzo, Fabrizio Fortuni, Federico Ugo, Fabrizio Meucci, Francesco Navazio, Alessandro Boccuzzi, Giacomo |
author_facet | Franchin, Luca Piroli, Francesco Demola, Pierluigi Mantovani, Francesca Iannaccone, Mario Manfredi, Roberto D’Ascenzo, Fabrizio Fortuni, Federico Ugo, Fabrizio Meucci, Francesco Navazio, Alessandro Boccuzzi, Giacomo |
author_sort | Franchin, Luca |
collection | PubMed |
description | BACKGROUNDS: Two recent randomized controlled trials (RCTs), the PROTECT-AF and the PREVAIL, showed that in atrial fibrillation (AF) patients, left atrial appendage closure (LAAC) is comparable to oral anticoagulants (OAC) in the prevention of stroke and could also possibly reduce mortality. Nevertheless, this net clinical benefit was not confirmed in the most recent RCT comparing LAAC vs. OAC, the PRAGUE-17 trial. AIM: aim of the present study was to evaluate the efficacy and safety of LAAC compared with OAC among available high-quality studies. METHODS: A systematic search of electronic databases (Medline, Scopus, Embase and the Cochrane Library) was performed to identify eligible RCTs and observational studies with propensity score matching (PSM) analysis. PRISMA guidelines were used for abstracting data and assessing data quality and validity. Outcomes of interest were the occurrence of cardiovascular death (CVD), all-cause death, all-type stroke, and major bleedings. RESULTS: A total of 3 RCTs and 7 PMS studies involving 25,700 patients were identified. 12,961 patients received LAAC while 12,739 received OAC therapy. After a median follow-up of 2.6 years (IQR 2–4.4), patients who received LAAC had lower risk of CVD (RR = 0.62; 95%CI, 0.51–0.74, I(2 )= 0%), all-cause death (RR = 0.67; 95% CI, 0.57–0.78, I(2) 68%) and major bleedings (RR = 0.68; 95%CI, 0.48–0.95 I(2 )= 87%) compared with patients on OAC. No difference was found between the two groups regarding strokes incidence (RR = 0.94; 95% CI, 0.77–1.15, I(2 )= 0%). CONCLUSIONS: According to this meta-analysis, LAAC has comparable efficacy in the prevention of stroke compared with OAC and a reduced risk of major bleedings, all-cause death and CVD that may be even larger with longer follow-up. SYSTEMATIC REVIEW REGISTRATION: https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=269768, identifier CRD42021269768. |
format | Online Article Text |
id | pubmed-10565038 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-105650382023-10-12 Efficacy and safety of left atrial appendage closure compared with oral anticoagulation in atrial fibrillation: a meta-analysis of randomized controlled trials and propensity-matched studies Franchin, Luca Piroli, Francesco Demola, Pierluigi Mantovani, Francesca Iannaccone, Mario Manfredi, Roberto D’Ascenzo, Fabrizio Fortuni, Federico Ugo, Fabrizio Meucci, Francesco Navazio, Alessandro Boccuzzi, Giacomo Front Cardiovasc Med Cardiovascular Medicine BACKGROUNDS: Two recent randomized controlled trials (RCTs), the PROTECT-AF and the PREVAIL, showed that in atrial fibrillation (AF) patients, left atrial appendage closure (LAAC) is comparable to oral anticoagulants (OAC) in the prevention of stroke and could also possibly reduce mortality. Nevertheless, this net clinical benefit was not confirmed in the most recent RCT comparing LAAC vs. OAC, the PRAGUE-17 trial. AIM: aim of the present study was to evaluate the efficacy and safety of LAAC compared with OAC among available high-quality studies. METHODS: A systematic search of electronic databases (Medline, Scopus, Embase and the Cochrane Library) was performed to identify eligible RCTs and observational studies with propensity score matching (PSM) analysis. PRISMA guidelines were used for abstracting data and assessing data quality and validity. Outcomes of interest were the occurrence of cardiovascular death (CVD), all-cause death, all-type stroke, and major bleedings. RESULTS: A total of 3 RCTs and 7 PMS studies involving 25,700 patients were identified. 12,961 patients received LAAC while 12,739 received OAC therapy. After a median follow-up of 2.6 years (IQR 2–4.4), patients who received LAAC had lower risk of CVD (RR = 0.62; 95%CI, 0.51–0.74, I(2 )= 0%), all-cause death (RR = 0.67; 95% CI, 0.57–0.78, I(2) 68%) and major bleedings (RR = 0.68; 95%CI, 0.48–0.95 I(2 )= 87%) compared with patients on OAC. No difference was found between the two groups regarding strokes incidence (RR = 0.94; 95% CI, 0.77–1.15, I(2 )= 0%). CONCLUSIONS: According to this meta-analysis, LAAC has comparable efficacy in the prevention of stroke compared with OAC and a reduced risk of major bleedings, all-cause death and CVD that may be even larger with longer follow-up. SYSTEMATIC REVIEW REGISTRATION: https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=269768, identifier CRD42021269768. Frontiers Media S.A. 2023-09-27 /pmc/articles/PMC10565038/ /pubmed/37829693 http://dx.doi.org/10.3389/fcvm.2023.1212161 Text en © 2023 Franchin, Piroli, Demola, Mantovani, Iannaccone, Manfredi, D'Ascenzo, Fortuni, Ugo, Meucci, Navazio and Boccuzzi. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) (https://creativecommons.org/licenses/by/4.0/) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Cardiovascular Medicine Franchin, Luca Piroli, Francesco Demola, Pierluigi Mantovani, Francesca Iannaccone, Mario Manfredi, Roberto D’Ascenzo, Fabrizio Fortuni, Federico Ugo, Fabrizio Meucci, Francesco Navazio, Alessandro Boccuzzi, Giacomo Efficacy and safety of left atrial appendage closure compared with oral anticoagulation in atrial fibrillation: a meta-analysis of randomized controlled trials and propensity-matched studies |
title | Efficacy and safety of left atrial appendage closure compared with oral anticoagulation in atrial fibrillation: a meta-analysis of randomized controlled trials and propensity-matched studies |
title_full | Efficacy and safety of left atrial appendage closure compared with oral anticoagulation in atrial fibrillation: a meta-analysis of randomized controlled trials and propensity-matched studies |
title_fullStr | Efficacy and safety of left atrial appendage closure compared with oral anticoagulation in atrial fibrillation: a meta-analysis of randomized controlled trials and propensity-matched studies |
title_full_unstemmed | Efficacy and safety of left atrial appendage closure compared with oral anticoagulation in atrial fibrillation: a meta-analysis of randomized controlled trials and propensity-matched studies |
title_short | Efficacy and safety of left atrial appendage closure compared with oral anticoagulation in atrial fibrillation: a meta-analysis of randomized controlled trials and propensity-matched studies |
title_sort | efficacy and safety of left atrial appendage closure compared with oral anticoagulation in atrial fibrillation: a meta-analysis of randomized controlled trials and propensity-matched studies |
topic | Cardiovascular Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10565038/ https://www.ncbi.nlm.nih.gov/pubmed/37829693 http://dx.doi.org/10.3389/fcvm.2023.1212161 |
work_keys_str_mv | AT franchinluca efficacyandsafetyofleftatrialappendageclosurecomparedwithoralanticoagulationinatrialfibrillationametaanalysisofrandomizedcontrolledtrialsandpropensitymatchedstudies AT pirolifrancesco efficacyandsafetyofleftatrialappendageclosurecomparedwithoralanticoagulationinatrialfibrillationametaanalysisofrandomizedcontrolledtrialsandpropensitymatchedstudies AT demolapierluigi efficacyandsafetyofleftatrialappendageclosurecomparedwithoralanticoagulationinatrialfibrillationametaanalysisofrandomizedcontrolledtrialsandpropensitymatchedstudies AT mantovanifrancesca efficacyandsafetyofleftatrialappendageclosurecomparedwithoralanticoagulationinatrialfibrillationametaanalysisofrandomizedcontrolledtrialsandpropensitymatchedstudies AT iannacconemario efficacyandsafetyofleftatrialappendageclosurecomparedwithoralanticoagulationinatrialfibrillationametaanalysisofrandomizedcontrolledtrialsandpropensitymatchedstudies AT manfrediroberto efficacyandsafetyofleftatrialappendageclosurecomparedwithoralanticoagulationinatrialfibrillationametaanalysisofrandomizedcontrolledtrialsandpropensitymatchedstudies AT dascenzofabrizio efficacyandsafetyofleftatrialappendageclosurecomparedwithoralanticoagulationinatrialfibrillationametaanalysisofrandomizedcontrolledtrialsandpropensitymatchedstudies AT fortunifederico efficacyandsafetyofleftatrialappendageclosurecomparedwithoralanticoagulationinatrialfibrillationametaanalysisofrandomizedcontrolledtrialsandpropensitymatchedstudies AT ugofabrizio efficacyandsafetyofleftatrialappendageclosurecomparedwithoralanticoagulationinatrialfibrillationametaanalysisofrandomizedcontrolledtrialsandpropensitymatchedstudies AT meuccifrancesco efficacyandsafetyofleftatrialappendageclosurecomparedwithoralanticoagulationinatrialfibrillationametaanalysisofrandomizedcontrolledtrialsandpropensitymatchedstudies AT navazioalessandro efficacyandsafetyofleftatrialappendageclosurecomparedwithoralanticoagulationinatrialfibrillationametaanalysisofrandomizedcontrolledtrialsandpropensitymatchedstudies AT boccuzzigiacomo efficacyandsafetyofleftatrialappendageclosurecomparedwithoralanticoagulationinatrialfibrillationametaanalysisofrandomizedcontrolledtrialsandpropensitymatchedstudies |